Page last updated: 2024-08-26

bosentan anhydrous and Bone Neoplasms

bosentan anhydrous has been researched along with Bone Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, LD; Castillo, CI; Dréau, D; Eddy, JM; Jewell, AN; McDermott, KA; Swamydas, M; Wyan, H	1
Carducci, MA; Lassiter, LK	1
Clemens, MG; Culberson, C; Dréau, D; Karaa, A; McKillop, IH; Wyan, H	1

Reviews

1 review(s) available for bosentan anhydrous and Bone Neoplasms

Article	Year
Endothelin receptor antagonists in the treatment of prostate cancer. Seminars in oncology, 2003, Volume: 30, Issue:5 Topics: Androgen Antagonists; Apoptosis; Atrasentan; Bone Neoplasms; Bosentan; Clinical Trials as Topic; Disease Progression; Drug Resistance, Neoplasm; Endothelin Receptor Antagonists; Endothelins; Forecasting; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; Pyrimidines; Pyrrolidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome	2003

Article

Year

Endothelin receptor antagonists in the treatment of prostate cancer.

Seminars in oncology, 2003, Volume: 30, Issue:5

Topics: Androgen Antagonists; Apoptosis; Atrasentan; Bone Neoplasms; Bosentan; Clinical Trials as Topic; Disease Progression; Drug Resistance, Neoplasm; Endothelin Receptor Antagonists; Endothelins; Forecasting; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; Pyrimidines; Pyrrolidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome

2003

Other Studies

2 other study(ies) available for bosentan anhydrous and Bone Neoplasms

Article	Year
The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer. Cancer investigation, 2010, Volume: 28, Issue:9 Topics: Animals; Antihypertensive Agents; Bone Neoplasms; Bosentan; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Inflammation Mediators; Interleukin-17; Interleukin-1alpha; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Burden; Tumor Necrosis Factor-alpha	2010
Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis. Clinical & experimental metastasis, 2006, Volume: 23, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Bosentan; Breast Neoplasms; Cell Division; Endothelin-1; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Neoplasm Metastasis; RNA, Messenger; Skin; Sulfonamides	2006

Article

Year

The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer.

Cancer investigation, 2010, Volume: 28, Issue:9

Topics: Animals; Antihypertensive Agents; Bone Neoplasms; Bosentan; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Inflammation Mediators; Interleukin-17; Interleukin-1alpha; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Burden; Tumor Necrosis Factor-alpha

2010

Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis.

Clinical & experimental metastasis, 2006, Volume: 23, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Bosentan; Breast Neoplasms; Cell Division; Endothelin-1; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Neoplasm Metastasis; RNA, Messenger; Skin; Sulfonamides

2006